NCT02322697View on ClinicalTrials.gov

Effect of Carnitine on Uremic Cardiomyopathy

NACompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

August 31, 2013

Primary Completion Date

October 31, 2014

Study Completion Date

October 31, 2014

Conditions
Disorder of Fatty Acid Metabolism
Interventions
DRUG

Intravenous administration of L-carnitine

Chronic intravenous administration of L-carnitine (1000mg on each dialysis session) for 1 year in hemodialysis patients

All Listed Sponsors
lead

Toujinkai Hospital

OTHER

NCT02322697 - Effect of Carnitine on Uremic Cardiomyopathy | Biotech Hunter | Biotech Hunter